← Leaderboards
Valerie I Brown
Childrens Hospital Of Philadelphia
$693,360
Attributed
$693,360
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138.7K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$693,360 · 1
By mechanism
K08$693,360 · 1
Top collaborators
No co-investigators on record.
Most similar at Childrens Hospital Of Philadelphia
Same institution · by research overlap
- Patrick A Zweidler-McKay$2,553,509
Others in their field
Top investigators on “Asparaginase”
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Mary V. Relling · St. Jude Children'S Research Hospital$14,971,629
- William E. Evans · St. Jude Children'S Research Hospital$10,116,831
- Sharon B. Murphy · Northwestern University$7,718,936
- Sara Lustigman · New York Blood Center$5,680,257
- Alejandro Gutierrez · Dana-Farber Cancer Inst$4,419,854
Research focus
AsparaginaseSirolimusLeukemiaDexamethasone/DoxorubicinAntineoplastic AgentsB-Cell DevelopmentCytotoxic ChemotherapyAdvisory CommitteesClassB LymphocyteBaseBone Marrow TransplantationCareerCci-779Chemotherapy-Oncologic ProcedureCellsChildChildhoodB-Cell LymphomasClinically RelevantB-LymphocytesClinical Trials, Phase IB Lymphoid MalignancyAcute Lymphocytic Leukemia
Grant awards (5)
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES$138,672
K08 · FY2008 · CA · contact PI
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES$138,672
K08 · FY2007 · CA · contact PI
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES$138,672
K08 · FY2006 · CA · contact PI
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES$138,672
K08 · FY2005 · CA
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES$138,672
K08 · FY2004 · CA